J. Gérain

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

Thierry Calandra, J. Gérain, Didier Heumann et al. · The American Journal of Medicine · 1991 · 447 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

Jean‐Paul Pirnay, Sarah Djebara, Griet Steurs et al. · Nature Microbiology · 2024 · 389 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide

Gláucia Zanetti, Didier Heumann, J. Gérain et al. · The Journal of Immunology · 1992 · 248 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.

J. D. Baumgartner, Didier Heumann, J. Gérain et al. · The Journal of Experimental Medicine · 1990 · 150 citations · Full text

Veterinary Medicine, Immunology, Immunoregulation +16

Blood inflammatory response to inhaled endotoxin in normal subjects

Olivier Michel, J. DUCHATEAU, Gavin Plat et al. · Clinical & Experimental Allergy · 1995 · 77 citations

Veterinary Medicine, Immunology, Internal Medicine +14